Arkéa Capital buys minority in Landanger

Arkéa joins majority backer 21 Invest and the Landanger family, who retains a minority stake.

21 Invest France entered exclusive negotiations to take a controlling stake in the Landanger group in May this year. The GP invested via 21 Centrale Partners V, according to Unquote Data. Ardian provided unitranche to support the transaction.

The GPs will strengthen Landanger's position in France by expanding its offering through innovation capacity, and will also help the business to expand abroad.

Company
Established in 1947 and based in Paris, Landanger manufactures reusable surgical instruments for open surgeries under the Landanger brands, as well as under the name Delacroix-Chevalier for cardiology instruments. It also makes ancillary products for orthopaedic surgeries under the brand Maire Didier. The company's revenues amounted to €25m in 2018.

People
Landanger – Benoit Landanger (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• France
• Healthcare
• France